SEC Company Response from BNB PLUS CORP. (BNBX) (CIK 0000744452) (BNBX) — Mar 6, 2015
BNB PLUS CORP. (BNBX) (CIK 0000744452)
Date: March 6, 2015 · CIK: 0000744452 · Accession: 0001571049-15-001739
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-202432
Letter
Applied DNA Sciences, Inc.
50 Health Sciences Drive
Stony Brook, NY 11790
March 6, 2015
VIA EDGAR
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attn: Gregory Dundas
Division of Corporation Finance
Re: Applied DNA Sciences, Inc.
Registration Statement on Form S-3
File No. 333-202432
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, Applied DNA Sciences, Inc. (the “Company”) hereby requests that the effectiveness of its Registration Statement on Form S-3 (File No. 333-202432) be accelerated so that such Registration Statement will become effective at 4:00 p.m., Eastern Time, on Tuesday, March 10, 2015, or as soon thereafter as practicable. In addition, the Company hereby acknowledges that:
· should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
· the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
· the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Very truly yours,
Applied DNA Sciences, Inc.
Show Raw Text
CORRESP
1
filename1.htm
Applied DNA Sciences, Inc.
50 Health Sciences Drive
Stony Brook, NY 11790
March 6, 2015
VIA EDGAR
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attn: Gregory Dundas
Division of Corporation Finance
Re:
Applied DNA Sciences, Inc.
Registration Statement on Form S-3
File No. 333-202432
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933,
as amended, Applied DNA Sciences, Inc. (the “Company”) hereby requests that the effectiveness of its Registration
Statement on Form S-3 (File No. 333-202432) be accelerated so that such Registration Statement will become effective
at 4:00 p.m., Eastern Time, on Tuesday, March 10, 2015, or as soon thereafter as practicable. In addition, the Company
hereby acknowledges that:
· should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose
the Commission from taking any action with respect to the filing;
· the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does
not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
· the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by
the Commission or any person under the federal securities laws of the United States.
Very truly yours,
Applied DNA Sciences, Inc.
By:
/s/ Beth Jantzen
Beth Jantzen
Chief Financial Officer